3D Echo Evaluation of the Ventricles in Sclero Associated Severe PAH

NCT02207868 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2018-05-23

No results posted yet for this study

Summary

The aim of the study is to document the left and right ventricular function in patients with sclerodermia associated pulmonal arterial hypertension via 3D echocardiography. The results of this study should help to generate hypothesis for further future studies.

The primary hypothesis is that the increased use of modern image guided methods could provide essential aspects for the follow up.

Conditions

Sponsors & Collaborators

  • Regina Steringer-Mascherbauer

    lead OTHER

Principal Investigators

  • Regina Steringer-Mascherbauer, MD · Krankenhaus der Elisabethinen Linz GmbH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02207868 on ClinicalTrials.gov